Clinical Trials Browser

Phase 1/2 × Terminated × mirdametinib × Clear all

NCT05580770 2026-05-01

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

23 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumor

NCT00147550 2013-09-13

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Phase 1/2 Terminated

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma